ATP5IF1 and cancer: In Figure 1, we summarize the metabolic reprograming to an enhanced glycolytic phenotype of cancer and non-cancer cells when the mitochondrial content of IF1 is increased by its overexpression, both in transiently and in stably transfected cells.